These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Regulation of normal and neoplastic human mast cell development in mastocytosis. Metcalfe DD Trans Am Clin Climatol Assoc; 2005; 116():185-203; discussion 203-4. PubMed ID: 16555614 [TBL] [Abstract][Full Text] [Related]
12. Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes. Picard M; Giavina-Bianchi P; Mezzano V; Castells M Clin Ther; 2013 May; 35(5):548-62. PubMed ID: 23642289 [TBL] [Abstract][Full Text] [Related]
13. The presence of mast cell clonality in patients with unexplained anaphylaxis. Gülen T; Hägglund H; Sander B; Dahlén B; Nilsson G Clin Exp Allergy; 2014 Sep; 44(9):1179-87. PubMed ID: 25039926 [TBL] [Abstract][Full Text] [Related]
14. Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis. Greiner G; Sprinzl B; Górska A; Ratzinger F; Gurbisz M; Witzeneder N; Schmetterer KG; Gisslinger B; Uyanik G; Hadzijusufovic E; Esterbauer H; Gleixner KV; Krauth MT; Pfeilstöcker M; Keil F; Gisslinger H; Nedoszytko B; Niedoszytko M; Sperr WR; Valent P; Hoermann G Blood; 2021 Jan; 137(2):238-247. PubMed ID: 32777817 [TBL] [Abstract][Full Text] [Related]
16. Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium. Valent P; Hartmann K; Bonadonna P; Gülen T; Brockow K; Alvarez-Twose I; Hermine O; Niedoszytko M; Carter MC; Hoermann G; Butterfield JH; Lyons JJ; Sperr WR; Greiner G; Sotlar K; Kluin-Nelemans HC; Schwaab J; Lange M; George TI; Siebenhaar F; Broesby-Olsen S; Jawhar M; Nedoszytko B; Castells M; Orfao A; Gotlib J; Reiter A; Horny HP; Triggiani M; Arock M; Metcalfe DD; Akin C J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1941-1950. PubMed ID: 35623575 [TBL] [Abstract][Full Text] [Related]
17. Targeted Treatment Options in Mastocytosis. Vaes M; Benghiat FS; Hermine O Front Med (Lausanne); 2017; 4():110. PubMed ID: 28775983 [TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches. Valent P; Akin C; Gleixner KV; Sperr WR; Reiter A; Arock M; Triggiani M Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216696 [TBL] [Abstract][Full Text] [Related]
20. A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis. Carter MC; Desai A; Komarow HD; Bai Y; Clayton ST; Clark AS; Ruiz-Esteves KN; Long LM; Cantave D; Wilson TM; Scott LM; Simakova O; Jung MY; Hahn J; Maric I; Metcalfe DD J Allergy Clin Immunol; 2018 Jan; 141(1):180-188.e3. PubMed ID: 28629749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]